Memorial Sloan Kettering Cancer Center

Call Our
Appointment Specialists

800-525-2225
Mon–Fri, 8:30 AM–5:30 PM, ET

Learn more »
For referring physicians »

Information by
Type of Disease

OnCancer

News and Insights from Memorial Sloan Kettering See all blog posts »

Epigenetics
Q&A

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

Friday, January 30, 2015
In the Clinic

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.

Wednesday, January 28, 2015
Pictured: Jaspreet Sandhu and Laura Leddy
Support

Urinary problems like incontinence and overactive bladder can be an issue for cancer survivors. At MSK, our surgeons can offer a range of solutions.

Monday, January 26, 2015

Our Clinical Trials

You may have access to new experimental treatments by participating in a clinical trial.

Learn more »

Pressroom

Find the latest press releases, media guidelines, and Memorial Sloan Kettering facts and figures.

Enter Pressroom »

Contact Media Staff »

Giving to Memorial Sloan Kettering

The fulfillment of our mission depends on your support.

Donate now

Explore ways to give »